BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31067829)

  • 1. Genotype⁻Phenotype Correlation in a New Fabry-Disease-Causing Mutation.
    Čerkauskaitė A; Čerkauskienė R; Miglinas M; Laurinavičius A; Ding C; Rolfs A; Vencevičienė L; Barysienė J; Kazėnaitė E; Sadauskienė E
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31067829
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients.
    Duro G; Anania M; Zizzo C; Francofonte D; Giacalone I; D'Errico A; Marsana EM; Colomba P
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent fabry disease and immunoglobulin a nephropathy: a case report.
    Zhou LN; Dong SS; Zhang SZ; Huang LW; Huang W
    BMC Nephrol; 2023 Nov; 24(1):324. PubMed ID: 37914990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Classical Phenotype of Fabry Disease with Novel Mutation Found by Kidney Biopsy, A Case Report.
    Matsumoto K; Ishii M; Mizuta M; Nakamura M; Matsumoto R; Ikeda Y; Yamasaki M; Fukuda M; Miyazono M
    Iran J Kidney Dis; 2023 Nov; 17(6):348-350. PubMed ID: 38043112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel nonsense mutation in α-galactosidase A that causes Fabry disease in a Chinese family.
    Peng Y; Pan M; Wang Y; Shen Z; Xu J; Xiong F; Xiao H; Miao Y
    Ren Fail; 2024 Dec; 46(2):2362391. PubMed ID: 38847497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation impact on Fabry disease.
    Di Risi T; Vinciguerra R; Cuomo M; Della Monica R; Riccio E; Cocozza S; Imbriaco M; Duro G; Pisani A; Chiariotti L
    Clin Epigenetics; 2021 Feb; 13(1):24. PubMed ID: 33531072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early renal failure in childhood in a male with Fabry disease.
    Hogh JN; Ebrahim H; Moochhala S; Ramaswami U
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing Fabry nephropathy: the challenge of multiple kidney disease.
    Esposito P; Caputo C; Repetto M; Somaschini A; Pietro B; Colomba P; Zizzo C; Parodi A; Zanetti V; Canepa M; Eustachi V; Sanguineri F; Mandich P; Viazzi F
    BMC Nephrol; 2023 Nov; 24(1):344. PubMed ID: 37990184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D313Y variant in two related end-stage renal disease patients - Pathogenic or not yet?
    Vicente R; Santos I; Coimbra M; Santos J; Santos R; Amoedo M; Pires C
    Nefrologia (Engl Ed); 2023; 43(5):636-639. PubMed ID: 36517364
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Li P; Xi Y; Zhang Y; Samad A; Lan W; Wu Y; Zhao J; Chen G; Wu C; Xiong Q
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-Phenotype Correlations in 293 Russian Patients with Causal Fabry Disease Variants.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Pakhomov A; Trufanova E; Alexeeva A; Sladkov D; Kuzenkova L; Asanov A; Fisenko A
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Fabry disease in patients with chronic kidney disease: A systematic review and meta-analysis.
    Linares D; Luna B; Loayza E; Taboada G; Ramaswami U
    Mol Genet Metab; 2023 Dec; 140(4):107714. PubMed ID: 37918171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cornea Verticillata in classical Fabry disease, first from Sri Lanka: a case report.
    Hewavitharana H; Jasinge E; Abeysekera H; Wanigasinghe J
    BMC Pediatr; 2020 Jul; 20(1):338. PubMed ID: 32641113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report:
    Simonetta I; Riolo R; Todaro F; Donadio V; Incensi A; Miceli S; Colomba P; Duro G; Tuttolomondo A
    Front Genet; 2023; 14():1122893. PubMed ID: 37779915
    [No Abstract]   [Full Text] [Related]  

  • 15. Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations.
    Izhar R; Borriello M; La Russa A; Di Paola R; De A; Capasso G; Ingrosso D; Perna AF; Simeoni M
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of papillary muscle hypertrophy in fabry disease.
    Cianciulli TF; Saccheri MC; Llobera MN; Balletti LR; Beck MA; Morita LA; Lax JA
    BMC Cardiovasc Disord; 2023 Aug; 23(1):424. PubMed ID: 37635225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of 10 patients with Fabry disease].
    Wang RZ; Xiao HB
    Zhonghua Nei Ke Za Zhi; 2024 Jan; 63(1):89-93. PubMed ID: 38186123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenesis in Fabry Disease.
    Roy A; Cumberland MJ; O'Shea C; Holmes A; Kalla M; Gehmlich K; Geberhiwot T; Steeds RP
    Curr Cardiol Rep; 2024 Apr; ():. PubMed ID: 38607539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry Disease Presenting as End-Stage Kidney Disease.
    Pahl MV; Hou J
    Glomerular Dis; 2023; 3(1):189-196. PubMed ID: 37901696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families.
    Cianci V; Pascarella A; Manzo L; Gasparini S; Marsico O; Mammì A; Rao CM; Franzutti C; Aguglia U; Ferlazzo E
    Metab Brain Dis; 2023 Aug; 38(6):1905-1912. PubMed ID: 37097439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.